{"id":5530,"date":"2022-10-03T08:15:06","date_gmt":"2022-10-03T15:15:06","guid":{"rendered":"https:\/\/allocare.caredx.com\/?p=5530"},"modified":"2022-10-03T08:15:13","modified_gmt":"2022-10-03T15:15:13","slug":"despite-recommendations-statin-use-not-ubiquitous-in-ckd-with-ascvd","status":"publish","type":"post","link":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/indexphp\/post\/2022\/10\/03\/despite-recommendations-statin-use-not-ubiquitous-in-ckd-with-ascvd\/","title":{"rendered":"Despite recommendations, statin use \u2018not ubiquitous\u2019 in CKD with ASCVD"},"content":{"rendered":"<span class=\"simplefavorite-button has-count loading\" data-postid=\"5530\" data-siteid=\"1\" data-groupid=\"1\" data-favoritecount=\"0\" style=\"\">Loading<span class=\"sf-icon-spinner-wrapper\"><i class=\"sf-icon-spinner\"><\/i><\/span><\/span>\n<p>Overall statin use among adults with chronic kidney disease is high, yet there have been only modest increases in the use of&nbsp;<a rel=\"noreferrer noopener\" href=\"https:\/\/www.healio.com\/news\/cardiology\/20220722\/statin-plus-ezetimibe-combination-alternative-strategy-to-doubled-statin-dose-in-ascvd\" target=\"_blank\">high\u2010intensity statins, ezetimibe<\/a>&nbsp;and PCSK9 inhibitors, data from a prospective 2\u2010year study show.<\/p>\n\n\n\n<p>Both the 2013 Kidney Disease: Improving Global Outcomes (KDIGO) and 2018 American College of Cardiology\/American Heart Association cholesterol guidelines recommend at least statin therapy for adults with non\u2010dialysis-dependent chronic kidney disease (CKD) and atherosclerotic CVD, as CKD is a major risk factor for disease progression,\u00a0<strong>Robert S. Rosenson, MD<\/strong>, director of metabolism and lipids for the Mount Sinai Health System and professor of medicine in cardiology at the Icahn School of Medicine at Mount Sinai, and colleagues wrote.\u00a0<a href=\"https:\/\/www.healio.com\/news\/cardiology\/20220927\/despite-recommendations-statin-use-not-ubiquitous-in-ckd-with-ascvd?utm_source=selligent&amp;utm_medium=email&amp;utm_campaign=news&amp;M_BT=7635131937835\">Read the full story <\/a>in Healio.<\/p>\n<span class=\"simplefavorite-button has-count loading\" data-postid=\"5530\" data-siteid=\"1\" data-groupid=\"1\" data-favoritecount=\"0\" style=\"\">Loading<span class=\"sf-icon-spinner-wrapper\"><i class=\"sf-icon-spinner\"><\/i><\/span><\/span>","protected":false},"excerpt":{"rendered":"<p>Loading Overall statin use among adults with chronic kidney disease is high, yet there have been only modest increases in the use of&nbsp;high\u2010intensity statins, ezetimibe&nbsp;and PCSK9 inhibitors, data from a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/indexphp\/post\/2022\/10\/03\/despite-recommendations-statin-use-not-ubiquitous-in-ckd-with-ascvd\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Despite recommendations, statin use \u2018not ubiquitous\u2019 in CKD with ASCVD&#8221;<\/span><\/a><\/p>\n","protected":false},"author":208,"featured_media":849,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":0,"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_tribe_blocks_recurrence_rules":"","_tribe_blocks_recurrence_description":"","_tribe_blocks_recurrence_exclusions":"","_ecp_custom_2":"","footnotes":""},"categories":[45,317,2],"tags":[1128,1129],"post_format":[],"Dislikes":"","Likes":"","simplefavorites_count":"","views":"1310","post_likes_plusCounter":"1","post_dislikes_plusCounter":"","acf":[],"_links":{"self":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts\/5530"}],"collection":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/users\/208"}],"replies":[{"embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/comments?post=5530"}],"version-history":[{"count":1,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts\/5530\/revisions"}],"predecessor-version":[{"id":5531,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts\/5530\/revisions\/5531"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/media\/849"}],"wp:attachment":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/media?parent=5530"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/categories?post=5530"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/tags?post=5530"},{"taxonomy":"post_format","embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/post_format?post=5530"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}